Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,130,162,341
+$702,768,970 QoQ
Shares Held
3,754,318
+190.6% QoQ
Ownership
2.81%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#8
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. ALNY ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,130,162,341 | 3,754,318 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $427,393,371 | 1,291,726 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $861,246,266 | 2,165,840 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $675,719,952 | 1,481,842 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $437,512,988 | 1,341,694 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $246,742,109 | 913,792 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $131,418,276 | 558,490 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $191,384,566 | 695,868 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $95,460,363 | 392,841 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,648,875 | 178,313 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $33,852,769 | 176,860 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $38,354,365 | 216,569 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $74,100,717 | 390,127 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $73,592,556 | 367,375 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $159,189,611 | 669,849 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $147,684,049 | 737,830 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,623,998 | 168,831 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $158,187,999 | 968,755 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $150,941,457 | 890,090 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $199,038,210 | 1,054,172 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $169,842,254 | 1,001,901 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $171,701,581 | 1,216,103 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $166,133,108 | 1,278,242 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $159,381,184 | 1,094,651 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $166,578,575 | 1,124,695 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $80,488,694 | 739,446 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||